Updated April 27 at 9:27pm

Pot firms gain as CVS, Walgreen competition a pipe dream

Americans seeking medical marijuana for anything from pain to seizures must turn to a patchwork of small startups for help as U.S. laws keep traditional pharmacies out of a market that may exceed $6 billion by 2019. More

To continue reading this article, please do one of the following.



Sign up to receive Providence Business News' newsletters
and breaking news alerts.  

health care

Pot firms gain as CVS, Walgreen competition a pipe dream

Posted:

NEW YORK – Americans seeking medical marijuana for anything from pain to seizures must turn to a patchwork of small startups for help as U.S. laws keep traditional pharmacies out of a market that may exceed $6 billion by 2019.

While more than 21 states have legalized pot for medicinal use, the drug remains illegal under federal law and banks are hesitant to accept money from its sale. That’s keeping drugstore chains CVS Caremark Corp., Walgreen Co. and Rite Aid Corp., out of the market, leaving local entrepreneurs in control.

“We aren’t going to see a big guy enter this market within the next few years,” said David Yang, an analyst with research firm IBISWorld. “There are just too many regulations and too many elements that make this impossible for them.”

In one state alone, Colorado, more than 400 companies are licensed as medical marijuana centers, with government officials predicting sales there could soon reach $1 billion. For Colorado businessman Kayvan Khalatbari, a former electrical engineer who started his business with just $4,000, federal limitations on the drug are a major benefit.

Khalatbari, who has poured $500,000 into pot production and $150,000 into a store, started in the industry by delivering medical marijuana door to door. This year, he expects sales of almost $2 million, which may rise to $5 million once he can also begin selling the drug commercially under Colorado law, he said.

“We’re making money, we’re employing people, we’re being a beacon of light for this industry and showing it can be done professionally,” Khalatbari said in a telephone interview. “That to me is a success.”

Federal law

Traditional pharmacies, meanwhile, face a hurdle that keeps them from competing with entrepreneurs like Khalatbari. Even though almost half of states and the District of Columbia accept the drug’s use for medical purposes, marijuana isn’t deemed legal by the federal government. The drug is classified as a Schedule I controlled substance, defined as having a high potential for abuse with no accepted medical use.

Schedule 1 drugs, which includes heroin, can’t by law be prescribed or dispensed. Pharmacies must register with the U.S. Drug Enforcement Agency to dispense controlled substances, making it illegal for them to sell medical marijuana.

Walgreen, Rite Aid and CVS said in separate statements they have no plans to sell medical marijuana. Doing so, according to CVS spokeswoman Carolyn Castel, would violate the company’s registration with the DEA.

Tax revenue

That may change if the U.S. Congress sees taxes on the drug as a way to raise money, said Brad Barker, an analyst with Bloomberg Industries in New York.

CVS Caremark, Walgreen Co, Rite Aid, marijuana sale, pot legalization, medical marijuana, Kayvan Khalatbari, U.S. Drug Enforcement Agency, Carolyn Castel, pharmaceutical cannabis, Marinol, Advanced Cannabis Solutions,
Next Page

Comments

No comments on this story | Please log in to comment by clicking here
Please log in or register to add your comment
Latest News